{"name":"Instituto Valenciano de Infertilidad, IVI VALENCIA","slug":"instituto-valenciano-de-infertilidad-ivi-valencia","ticker":"","exchange":"","domain":"ivi-fertilite.fr","description":"","hq":"Valencia","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":15,"colorKey":"oncology","drugs":[{"name":"Agonist GnRH Acetate Triptoreline","genericName":"Agonist GnRH Acetate Triptoreline","slug":"agonist-gnrh-acetate-triptoreline","indication":"Other","status":"marketed"},{"name":"Menopur®, Ferring","genericName":"Menopur®, Ferring","slug":"menopur-ferring","indication":"Controlled ovarian hyperstimulation in assisted reproductive technology (ART) cycles","status":"marketed"},{"name":"rFSH: Follicle Stimulating Hormone","genericName":"rFSH: Follicle Stimulating Hormone","slug":"rfsh-follicle-stimulating-hormone","indication":"Induction of ovulation in women with polycystic ovary syndrome (PCOS) or other ovulatory disorders","status":"phase_3"},{"name":"Agonist GnRH; estradiol Valerate; progesterone","genericName":"Agonist GnRH; estradiol Valerate; progesterone","slug":"agonist-gnrh-estradiol-valerate-progesterone","indication":"Assisted reproductive technology (ART) / in vitro fertilization (IVF) support","status":"marketed"},{"name":"Antagonist GnRH Cetrotide","genericName":"Antagonist GnRH Cetrotide","slug":"antagonist-gnrh-cetrotide","indication":"Prevention of premature luteinizing hormone surge in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology (in vitro fertilization)","status":"marketed"},{"name":"COS with GnRH antagonists and HP-HMG","genericName":"COS with GnRH antagonists and HP-HMG","slug":"cos-with-gnrh-antagonists-and-hp-hmg","indication":"Infertility treatment via controlled ovarian stimulation for in vitro fertilization (IVF)","status":"marketed"},{"name":"COS with GnRH antagonists and rFSH","genericName":"COS with GnRH antagonists and rFSH","slug":"cos-with-gnrh-antagonists-and-rfsh","indication":"Other","status":"marketed"},{"name":"Cetrorelix and Leuprolide","genericName":"Cetrorelix and Leuprolide","slug":"cetrorelix-and-leuprolide","indication":"Controlled ovarian hyperstimulation in assisted reproductive technology (ART) / in vitro fertilization (IVF)","status":"marketed"},{"name":"FSH+LH","genericName":"FSH+LH","slug":"fsh-lh","indication":"Infertility treatment via controlled ovarian hyperstimulation for assisted reproductive technology (ART)","status":"phase_3"},{"name":"Folitropin Beta","genericName":"Folitropin Beta","slug":"folitropin-beta","indication":"Other","status":"phase_1"},{"name":"Ganirelix (GnRH antagonist)","genericName":"Ganirelix (GnRH antagonist)","slug":"ganirelix-gnrh-antagonist","indication":"Prevention of premature luteinizing hormone surge in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology (ART)","status":"phase_3"},{"name":"Provera 10 mg.","genericName":"Provera 10 mg.","slug":"provera-10-mg","indication":"Contraception","status":"phase_3"},{"name":"r-FSH","genericName":"r-FSH","slug":"r-fsh","indication":"Infertility in women undergoing assisted reproductive technology (ART)","status":"marketed"},{"name":"r-FSH plus HP-hMG","genericName":"r-FSH plus HP-hMG","slug":"r-fsh-plus-hp-hmg","indication":"Ovarian stimulation for assisted reproductive technology (ART) including in vitro fertilization (IVF)","status":"marketed"},{"name":"rFSH (Gonal®,","genericName":"rFSH (Gonal®,","slug":"rfsh-gonal","indication":"Infertility in women undergoing assisted reproductive technology (ART) / in vitro fertilization (IVF)","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Tryptorelin","genericName":"Tryptorelin","slug":"tryptorelin","indication":"Advanced Prostatic Carcinoma","status":"marketed"}]}],"pipeline":[{"name":"Agonist GnRH Acetate Triptoreline","genericName":"Agonist GnRH Acetate Triptoreline","slug":"agonist-gnrh-acetate-triptoreline","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Menopur®, Ferring","genericName":"Menopur®, Ferring","slug":"menopur-ferring","phase":"marketed","mechanism":"Menopur is a purified preparation of human menopausal gonadotropins (hMG) containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) that stimulates ovarian follicle development and hormone production.","indications":["Controlled ovarian hyperstimulation in assisted reproductive technology (ART) cycles","Ovulation induction in anovulatory women"],"catalyst":""},{"name":"rFSH: Follicle Stimulating Hormone","genericName":"rFSH: Follicle Stimulating Hormone","slug":"rfsh-follicle-stimulating-hormone","phase":"phase_3","mechanism":"rFSH stimulates follicular growth and maturation in the ovaries.","indications":["Induction of ovulation in women with polycystic ovary syndrome (PCOS) or other ovulatory disorders","Assisted reproductive technology (ART) such as in vitro fertilization (IVF)"],"catalyst":""},{"name":"Agonist GnRH; estradiol Valerate; progesterone","genericName":"Agonist GnRH; estradiol Valerate; progesterone","slug":"agonist-gnrh-estradiol-valerate-progesterone","phase":"marketed","mechanism":"This combination suppresses endogenous gonadotropins via GnRH agonist while providing exogenous estradiol and progesterone to support the luteal phase during assisted reproductive cycles.","indications":["Assisted reproductive technology (ART) / in vitro fertilization (IVF) support","Controlled ovarian hyperstimulation in infertility treatment"],"catalyst":""},{"name":"Antagonist GnRH Cetrotide","genericName":"Antagonist GnRH Cetrotide","slug":"antagonist-gnrh-cetrotide","phase":"marketed","mechanism":"Cetrotide is a GnRH antagonist that directly blocks gonadotropin-releasing hormone receptors to suppress luteinizing hormone and follicle-stimulating hormone secretion.","indications":["Prevention of premature luteinizing hormone surge in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology (in vitro fertilization)"],"catalyst":""},{"name":"COS with GnRH antagonists and HP-HMG","genericName":"COS with GnRH antagonists and HP-HMG","slug":"cos-with-gnrh-antagonists-and-hp-hmg","phase":"marketed","mechanism":"This protocol combines controlled ovarian stimulation (COS) with GnRH antagonists to suppress premature luteinizing hormone surge and HP-HMG (highly purified human menopausal gonadotropin) to stimulate multiple follicle development for assisted reproductive technology.","indications":["Infertility treatment via controlled ovarian stimulation for in vitro fertilization (IVF)","Assisted reproductive technology requiring multiple oocyte retrieval"],"catalyst":""},{"name":"COS with GnRH antagonists and rFSH","genericName":"COS with GnRH antagonists and rFSH","slug":"cos-with-gnrh-antagonists-and-rfsh","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cetrorelix and Leuprolide","genericName":"Cetrorelix and Leuprolide","slug":"cetrorelix-and-leuprolide","phase":"marketed","mechanism":"Cetrorelix and leuprolide work together to suppress the pituitary-gonadal axis by blocking GnRH signaling, preventing premature luteinizing hormone surge during controlled ovarian hyperstimulation for assisted reproduction.","indications":["Controlled ovarian hyperstimulation in assisted reproductive technology (ART) / in vitro fertilization (IVF)","Prevention of premature luteinizing hormone surge during fertility treatment"],"catalyst":""},{"name":"FSH+LH","genericName":"FSH+LH","slug":"fsh-lh","phase":"phase_3","mechanism":"FSH and LH are gonadotropins that stimulate follicle development and ovulation in women, used to induce ovarian stimulation for assisted reproductive technologies.","indications":["Infertility treatment via controlled ovarian hyperstimulation for assisted reproductive technology (ART)","In vitro fertilization (IVF) and embryo transfer"],"catalyst":""},{"name":"Folitropin Beta","genericName":"Folitropin Beta","slug":"folitropin-beta","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ganirelix (GnRH antagonist)","genericName":"Ganirelix (GnRH antagonist)","slug":"ganirelix-gnrh-antagonist","phase":"phase_3","mechanism":"Ganirelix blocks gonadotropin-releasing hormone (GnRH) receptors to suppress luteinizing hormone (LH) and prevent premature ovulation during assisted reproductive procedures.","indications":["Prevention of premature luteinizing hormone surge in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology (ART)"],"catalyst":""},{"name":"Provera 10 mg.","genericName":"Provera 10 mg.","slug":"provera-10-mg","phase":"phase_3","mechanism":"Provera (medroxyprogesterone acetate) is a synthetic progestin that suppresses gonadotropin secretion and inhibits ovulation by acting on the hypothalamic-pituitary-ovarian axis.","indications":["Contraception","Hormone replacement therapy","Treatment of abnormal uterine bleeding"],"catalyst":""},{"name":"Tryptorelin","genericName":"Tryptorelin","slug":"tryptorelin","phase":"marketed","mechanism":"Gonadotropin-releasing hormone receptor, Gonadotropin-releasing hormone receptor","indications":["Advanced Prostatic Carcinoma"],"catalyst":""},{"name":"r-FSH","genericName":"r-FSH","slug":"r-fsh","phase":"marketed","mechanism":"Recombinant follicle-stimulating hormone (r-FSH) stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment.","indications":["Infertility in women undergoing assisted reproductive technology (ART)","Ovulation induction in anovulatory women"],"catalyst":""},{"name":"r-FSH plus HP-hMG","genericName":"r-FSH plus HP-hMG","slug":"r-fsh-plus-hp-hmg","phase":"marketed","mechanism":"A combination of recombinant follicle-stimulating hormone (r-FSH) and highly purified human menopausal gonadotropin (HP-hMG) that stimulates ovarian follicle development and hormone production for assisted reproductive technology.","indications":["Ovarian stimulation for assisted reproductive technology (ART) including in vitro fertilization (IVF)"],"catalyst":""},{"name":"rFSH (Gonal®,","genericName":"rFSH (Gonal®,","slug":"rfsh-gonal","phase":"marketed","mechanism":"rFSH (recombinant follicle-stimulating hormone) stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment.","indications":["Infertility in women undergoing assisted reproductive technology (ART) / in vitro fertilization (IVF)","Anovulation and ovulatory disorders in women seeking fertility treatment"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":16,"phaseCounts":{"marketed":11,"phase_3":4,"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}